Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

UK Life Sciences Strategy - one year on

UK to introduce DNA mapping for cancer and rare diseases

Will sequence the genomes of up to 100,000 patients within five years

- PMLiVE

Boehringer takes leukaemia drug volasertib into phase III

Shows positive results in a difficult-to-treat patient population

GSK teams up with Vodafone for mHealth initiative

Aims to use mobile technology to improve childhood vaccination rates in Mozambique

- PMLiVE

Biogen Idec licenses antisense drugs from Isis in $630m deal

Gains neurological and neuromuscular disorder projects

- PMLiVE

Amgen continues spending spree, acquires deCode Genetics

Will pay $415m for Icelandic genetic information firm

Ronald Berenson to lead Aequus BioPharma

Joins the Cell Therapeutics subsidiary as president and CEO

- PMLiVE

ASH meeting hears of progress with myelofibrosis drugs

New studies suggest momentum is for use of Janus kinase (JAK) inhibitors

- PMLiVE

MHRA streamlines POM-OTC reclassification rules

Aims to speed the process of switching drug status from prescription-only to over-the-counter

- PMLiVE

Eliquis meets targets as long-term VTE therapy

Pfizer and BMS report positive phase III data for the Factor Xa inhibitor

- PMLiVE

Merck KGaA picks Constantin Fest to lead investor relations

He succeeds Joshua Young who will leave the company and move to the US

- PMLiVE

INC Research appoints Robert Ryan

Joins CRO's new Strategic Advisory Services unit

- PMLiVE

Tough times for pharma in Portugal

Industry body warns of paucity of essential medicines and damage to industry reputation

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links